In addition, NT5E expression and its generation of adenosine may relate to breast cancer progression and increased expression of CD73 in ER-negative cells may serve as a novel marker for more aggressive breast carcinoma (Kabbani et al. 2007; Kato et al. 2007; Rinner et al. 2007). Here, NT5E is linked to breast cancer.